PRA Health Sciences, Inc. (PRAH) Financial Statements (2024 and earlier)

Company Profile

Business Address 4130 PARKLAKE AVENUE
RALEIGH, NC 27612
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)
Annual | Quarterly

3/31/2021
MRQ
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 506236144192145121
Cash and cash equivalents 506236144192145121
Restricted cash and investments  00155
Receivables 844659568627439415
Other undisclosed current assets 1109170573633
Total current assets: 1,461986782877625574
Noncurrent Assets
Operating lease, right-of-use asset 178186✕✕✕✕
Property, plant and equipment 1951811551438881
Long-term investments and receivables    001
Long-term investments    001
Intangible assets, net (including goodwill) 2,2912,1412,1992,2961,4461,549
Goodwill 1,6911,5031,4951,5129721,015
Intangible assets, net (excluding goodwill) 600639704784474534
Deferred costs     22
Deferred income tax assets 1510✕✕✕✕
Other noncurrent assets 373740312419
Deferred tax assets, net✕✕✕  73
Other undisclosed noncurrent assets 331011  
Total noncurrent assets: 2,7182,5592,4042,4811,5661,655
TOTAL ASSETS: 4,1793,5443,1863,3582,1902,229
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 212181225207167160
Interest and dividends payable 253346
Taxes payable 3244142619
Employee-related liabilities 1501191341268678
Accounts payable 575544655157
Deferred revenue 733506✕✕✕✕
Debt 2563 2931 
Business combination, contingent consideration, liability   83   
Other liabilities 434543453436
Deferred revenue and credits✕✕✕✕469333334
Contract with customer, liability✕✕✕441✕✕✕
Other undisclosed current liabilities 253223107222  
Total current liabilities: 1,2661,017899972564530
Noncurrent Liabilities
Long-term debt and lease obligation 1,3181,3131,0821,225797890
Long-term debt, excluding current maturities 1,1591,1401,0821,225797890
Liabilities, other than long-term debt 11612553112100107
Deferred tax liabilities, net✕✕✕  7482
Deferred income tax liabilities 6379✕✕✕✕
Other liabilities 5246531122625
Operating lease, liability 159172✕✕✕✕
Other undisclosed noncurrent liabilities   101112  
Total noncurrent liabilities: 1,4331,4371,2361,450897996
Total liabilities: 2,6992,4542,1352,4221,4611,526
Equity
Equity, attributable to parent 1,4791,0901,045931729703
Common stock 111111
Additional paid in capital 1,1371,006961905879828
Accumulated other comprehensive loss (99)(160)(171)(136)(225)(132)
Retained earnings 440243255161746
Equity, attributable to noncontrolling interest   66  
Total equity: 1,4791,0901,051936729703
TOTAL LIABILITIES AND EQUITY: 4,1793,5443,1863,3582,1902,229

Income Statement (P&L) ($ in millions)
Annual | Quarterly

3/31/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 3,1833,0662,8722,2591,8121,614
Revenue, net✕✕✕✕2,2591,8121,614
Cost of revenue
(Cost of Goods and Services Sold)		    (1,595)(1,264)(1,125)
Gross profit: 3,1833,0662,872665547489
Operating expenses (453)(396)(372)(322)(271)(247)
Other undisclosed operating loss (2,402)(2,306)(2,219)(166)(114)(78)
Operating income: 328364281176162164
Nonoperating income (expense) (26)(2)(1)(40)2513
Gain (loss), foreign currency transaction, before tax (25)(2)(1)(40)2414
Other nonoperating income (expense) (0)0(0)(0)1(1)
Interest and debt expense (0)(1)(1)(15)(38) 
Other undisclosed loss from continuing operations before equity method investments, income taxes (43)(55)(57)(47)(55)(62)
Income from continuing operations before equity method investments, income taxes: 2593062227594115
Income (loss) from equity method investments   003(3)
Income from continuing operations before income taxes: 2593062227597112
Income tax expense (benefit) (62)(63)(67)13(28)(30)
Income from continuing operations: 197243154876882
Income before gain (loss) on sale of properties:✕197243154876882
Net income: 197243154876882
Net loss attributable to noncontrolling interest  (0)(1)(0)  
Net income attributable to parent: 197243154876882
Other undisclosed net income available to common stockholders, basic    0  
Net income available to common stockholders, diluted: 197243154876882

Comprehensive Income ($ in millions)
Annual | Quarterly

3/31/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income: 197243154876882
Other comprehensive income (loss) 619(34)88(92)(63)
Comprehensive income (loss): 258252120175(24)19
Comprehensive loss, net of tax, attributable to noncontrolling interest  (0)(1)(0)  
Comprehensive income (loss), net of tax, attributable to parent: 258252120175(24)19

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: